Get started

Alpine

ALPN and VRTX may merge surge of bullish momentum LONGAlpine is a biotech stock that had an earnings report beating estimates two weeks ago. It is now reaching for all-time highs. That said, it is burning cash just slowing down the burn. Both revenue and earnings showed remarkable improvement as compared with the previous quarter. The bullish momentum of price and volume is obvious on the weeky chart with the print of a massive bullish engulfing candle. Another earnings report is due in 4 weeks. In the meanwhile, the news catalyst is VRTX and ALPN may be merging. www.tradingview.com / I will take a risky long trade here with a stop loss at 50 and a profit first target of 80 and the second at 90.
ALong
by AwesomeAvani
Vertex Pharmaceuticals Set to Buy Alpine Sciences For $4.9 BlnIn a strategic move set to shake up the biotech landscape, Vertex Pharmaceuticals ( NASDAQ:VRTX ) has announced its acquisition of Alpine Immune Sciences ( NASDAQ:ALPN ) in a blockbuster $4.9 billion deal. The news, which sent shockwaves through the market, made Alpine Immune Sciences ( NASDAQ:ALPN ) stock surge by 20.8% in Wednesday's Trading Session. Alpine Immune Sciences ( NASDAQ:ALPN ), a rising star in the biotech sphere, has captured attention with its lead product targeting IgA nephropathy, a debilitating chronic kidney disease with significant unmet medical needs. With a Phase 3 study slated to kick off later this year, Alpine's innovative approach has garnered interest from industry giants like Vertex. The acquisition aligns with Vertex's strategic vision to expand its footprint in kidney diseases, an area of immense medical significance. By adding Alpine's promising lead drug, povetacicept, to its arsenal, Vertex aims to address not only IgA nephropathy but also other autoimmune conditions affecting the kidneys, such as membranous nephropathy and lupus nephritis. For Vertex CEO Mitchell Gold, the acquisition represents a pivotal moment in the company's trajectory. "This marks a new chapter for Alpine," Gold stated, emphasizing povetacicept's potential to redefine treatment paradigms in autoimmune and inflammatory diseases. The move comes at a time when Vertex is already making strides in kidney disease treatments, particularly with its experimental therapy for APOL1-mediated kidney disease. By combining forces with Alpine, Vertex aims to accelerate its efforts in addressing the complex needs of patients grappling with kidney-related ailments. Alpine's stellar performance on the market, with a perfect Relative Strength Index (RSI) of 82 underscores the market's confidence in the company's innovative approach and potential for growth. With the deal expected to close later this quarter, all eyes are on Vertex as it embarks on this transformative journey in the realm of immunological-focused therapies. As Vertex solidifies its position as a leader in biopharmaceutical innovation, the acquisition of Alpine Immune Sciences signals a bold step forward in its mission to pioneer groundbreaking treatments for patients worldwide.
ALong
by DEXWireNews
ALPINEUSDT.1DOn this daily chart for ALPINE/USDT, we're presented with an outlook that incorporates the RSI (Relative Strength Index) and MACD (Moving Average Convergence Divergence) indicators along with key levels of support (S1, S2) and resistance (R1, R2). The RSI, sitting just above the neutral 50 mark at 52.04, suggests a slight bullish bias but indicates that the market is neither overbought nor oversold at the moment. The MACD is almost flat and very close to the zero line, indicating that there is no strong momentum in either direction. Price action is currently between S1 at $2.000 and R1 at $2.884, with the price at the time of the screenshot at $2.520. This suggests a consolidation phase within this range. The fact that the price is maintaining above the psychological level of $2.000 (S1) could be seen as a potentially bullish signal, as it may serve as a strong support level. A break above R1 would indicate a potential bullish continuation, possibly heading towards R2. However, if the price breaks below S1, it could suggest a bearish reversal with the possibility of the price moving down to test the next support at S2 ($1.755). For trading strategies, one might look for confirmation of a breakout above R1 with increased volume as a sign of bullish strength. Conversely, a drop below S1 with significant volume could indicate bearish momentum, and traders might look for short opportunities or exit long positions. As always, additional analysis of ALPINE’s market conditions and potential news events should be considered in any trading decision. It's also essential to implement a sound risk management strategy, potentially setting stop-loss orders near the S1 level to manage downside risk.
by MarsSignals
ALPINE ANALYSISFirst of all, note that ALPINE's movements are full of shadows and move slowly. ALPINE seems to be in a large diametric that has just finished wave D. Wave D appears to have been a triangle. The green area is a suitable place for a buy/long position. Closing a daily candle below the invalidation level will violate the analysis For risk management, please don't forget stop loss and capital management When we reach the first target, save some profit and then change the stop to entry Comment if you have any questions Thank You
Long
by behdark
ALPINEUSDT.1HBased on the given market data, ALPINE is currently trading at $1.983 against USDT. The 4-hour chart shows that the Relative Strength Index (RSI) is at 69.59, which is close to the overbought territory (above 70) and could indicate a potential price pullback. The Moving Average Convergence Divergence (MACD) is slightly negative (-0.001), suggesting a bearish trend. The current price is slightly below the upper Bollinger Band (BB) of $1.997, which often suggests a potential pullback towards the mean. In terms of support and resistance levels on the 4-hour chart, the first, second, and third support levels are at $1.917, $1.883, and $1.809 respectively. The first, second, and third resistance levels are at $2.112, $2.180, and $2.300 respectively. On the daily chart, the RSI is at 55.52, indicating a more balanced market. The MACD is positive (0.018) which suggests a bullish trend. The current price is below the upper Bollinger Band at $2.062, indicating room for potential upside. The support levels on the daily chart are at $1.886, $1.800, and $1.761, while the resistance levels are at $2.117, $2.192, and $2.300. On the weekly chart, the RSI is at 49.36, indicating a balanced market, and the MACD is negative (-0.070), suggesting a bearish trend. The support levels are at $1.817, $1.601, and $1.500, while the resistance levels are at $2.210, $2.310, and $2.475. In conclusion, ALPINE is showing mixed signals across different time frames. The short-term 4-hour chart is indicating a potential price pullback, while the daily chart suggests room for potential upside. The weekly chart suggests a bearish trend. Therefore, it is recommended to monitor the market closely and make decisions based on further market movements and individual risk tolerance.
by MarsSignals
$ALPINE/#BTC [#Alpine F1 Team Fan Token]: Resistance_BreakoutWe've detected a Resistance Breakout and Confirmation on the $ALPINE / $BTC chart. The price has broken above a key resistance level and has been confirmed by a strong candle, indicating a potential bullish trend. The next resistance key levels are at 0.0001291 | 0.00013644 | 0.00015263 and the major support zones are respectively at 0.00011291 | 0.00010406 | 0.00008787. We may consider entering a trade at the current price zone at 0.0001284 and targetting higher levels. Technical Metrics : Current price: 0.0001284 24H Volume: 13.9262 Ƀ 24H Price change: 2.984% - Pivot Points - Levels : Resistance: 0.0001291 | 0.00013644 | 0.00015263 Support: 0.00011291 | 0.00010406 | 0.00008787 Indicators recommandation : Oscillators: NEUTRAL Moving Averages: STRONG_BUY Technical Indicators Summary : BUY - In-depth ALPINEBTC technical analysis on > Tradingview TA page Welcome to the home of charting big: TradingView Benefit from a ton of financial analysis features, instruments and data. Have a look around, and if you do choose to go with an upgraded plan, you'll get up to $30. Discover it here
A
by Crypto2AF
Alpine F1 Team Fan Token formed bullish Gartley upto 15% pumpHi dear friends, hope you are well and welcome to the new trade setup of Alpine F1 Team Fan Token (ALPINE) with US Dollar pair. Previously we caught a nice pump of ALPINE: This time on a 2-hr time frame, CRV has formed a bullish Gartley pattern. At the moment, after the completion of final leg the priceline has slightly moved up, therefore, we can wait for some correction to buy it from the buying zone. Note: Above idea is for educational purpose only. It is advised to diversify and strictly follow the stop loss, and don't get stuck with trade
Long
by moon333